Copyright © 2026 Peptides Costa Rica, All Rights Reserved.

Retatrutide 25mg
₡ 76,900
Retatrutide 25mg is a synthetic investigational peptide formulated for laboratory research. It targets GIP, GLP-1, and glucagon receptor pathways associated with metabolism, appetite regulation, and energy balance. Each vial contains 25mg of Retatrutide and should be used for research purposes only.
- Verified COA Available

Free BAC Water
Included in every order
You don't need to add it.
Sin existencias
Product Information
Retatrutide 25 mg is an investigational synthetic peptide, also known by the research code LY3437943. It works as a triple hormone-receptor agonist by activating the GIP, GLP-1, and glucagon receptor pathways within a single molecule. Researchers are studying this combined mechanism for its potential effects on appetite regulation, glucose metabolism, insulin response, energy expenditure, body composition, and weight reduction.
The compound has attracted significant research interest because it targets three complementary metabolic pathways rather than only one or two. Clinical studies are evaluating retatrutide in participants with obesity, overweight, type 2 diabetes, cardiovascular disease, obstructive sleep apnea, and other weight-related conditions. Published and ongoing trials have reported promising findings, but its long-term safety and effectiveness are still being assessed.
The 25 mg label refers to the stated quantity of material in the container and does not represent an approved or recommended individual dose. Retatrutide remains an investigational compound and is not currently approved for general medical or public use. Product identity, purity, storage conditions, and other quality details should be confirmed through the supplier’s current batch-specific Certificate of Analysis.
Technical Specifications
| Specification | Value |
|---|---|
| Product Name | Retatrutide 25 mg |
| Research Code | LY3437943 |
| Compound Type | Synthetic modified peptide |
| Mechanism | GIPR, GLP-1R and GCGR triple agonist |
| CAS Number | 2381089-83-2 |
| PubChem CID | 171390338 |
| UNII | NOP2Y096GV |
| Molecular Formula | C221H342N46O68 |
| Molecular Weight | Approximately 4731.33 g/mol |
| Amino-Acid Count | 39 residues |
| Structural Modification | C20 fatty-acid moiety attached through a linker |
| Appearance | Batch and formulation specific; verify through the Certificate of Analysis |
| Purity | Batch specific; do not state a percentage without verified analytical testing |
| Solubility | Formulation specific; refer to manufacturer documentation |
| Storage | Follow the supplier’s validated stability data and batch documentation |
Specification
Value
Product Name:
N/A
Compound Type:
N/A
CAS Number:
N/A
PubChem CID:
N/A
Molecular Formula:
N/A
Molecular Weight (g/mol):
N/A
Amino Acid Count:
N/A
Amino Acid Sequence:
N/A
Synonyms / Other Names:
N/A
Appearance:
N/A
Purity:
N/A
Solubility:
N/A
Storage — Sealed:
N/A
Storage — After Reconstitution:
N/A
Why Choose Peptides Costa Rica?
We specialize in supplying high-purity research peptides with a focus on transparency, fast domestic delivery, and dedicated customer support.
Third-Party Lab Tested
All Peptides Costa Rica products are independently tested for purity, identity, and quality. Each batch is reviewed for peptide integrity, purity levels, and contaminants, with a COA included.
FREE Shipping Over ₡92,000
Orders over ₡92,000 qualify for free standard shipping to approved locations. Each package is securely prepared, shipped discreetly, and supported with tracking for reliable fulfillment.
Research-Grade Peptides
Peptides Costa Rica supplies research-grade peptides made under strict quality-control standards. Products are synthesized for high purity & provided in stable lyophilized form for laboratory research.
Trusted Peptide Supplier
Peptides Costa Rica focuses on transparent sourcing, verified testing, and consistent product quality. Researchers rely on our peptide collections for dependable products, service & support.
Key Benefits
What You Get
Retatrutide is being studied for its potential role in appetite regulation, body-weight reduction, glucose management, and broader metabolic health. Its unique triple-receptor mechanism activates GIP, GLP-1, and glucagon pathways at the same time, allowing researchers to explore several metabolic processes through a single compound. Retatrutide remains investigational and is not currently approved for medical or public use.
Triple Receptor Support
Activates GIP, GLP-1, and glucagon receptors to support research into multiple metabolic pathways within one compound.
Weight-Management Research
Clinical studies are evaluating its potential to reduce appetite, increase fullness, and support significant body-weight reduction.
Metabolic Health Research
Researchers are studying its possible effects on glucose regulation, insulin sensitivity, energy expenditure, body composition, and liver fat.
You May Also Like

Ordering Peptides in Costa Rica
Peptides Costa Rica serves customers only within Costa Rica.
To place an order:
Review product availability and pricing.
Contact us directly to confirm current stock.
Complete payment using one of the following methods:
• SINPE Móvil
• PayPal
• Cash
We arrange delivery within Costa Rica. Now get easy online checkout with all the given payment options. Simply add your preferred product in cart and place your order. We also handle orders directly to make sure your items are available before you pay.
Customer Reviews
Insights and experiences from from our growing community of satisfied customers.
Add a review
Rating*
0/5
* Rating is required
Your review
* Review is required
Name
* Name is required
Email
* Email is required
* Please tick the checkbox to proceed
0.0
Based on 0 reviews
| 5 star | 0% | |
| 4 star | 0% | |
| 3 star | 0% | |
| 2 star | 0% | |
| 1 star | 0% |
0 of 0 reviews
Sorry, no reviews match your current selections
Trusted Source Section
We provide high-quality research compounds with a focus on purity, consistency, and transparency. All products are carefully sourced, reliably handled, and supported with fast delivery across Costa Rica.
Bulk Savings
Save more with bulk purchases. Buy five or more vials of the same product and get 15% off with clear, upfront pricing and no hidden conditions.
Simple Ordering Process
Place orders through a simple process—review products, confirm availability, choose your payment method, and arrange delivery within Costa Rica.
Flexible Payment Options
Choose from secure payment options including SINPE Móvil, Zelle, PayPal, or cash for smooth and convenient transactions.
Transparency & Documentation
We provide Certificates of Analysis along with clear communication, verified stock, and straightforward pricing for complete trust.
Common Questions
Frequently Asked Questions
What is Retatrutide 25 mg and how does it work? +
Retatrutide, also known as LY3437943, is an investigational synthetic peptide that activates GIP, GLP-1 and glucagon receptors. Researchers are studying this triple-receptor mechanism for its potential effects on appetite, metabolic signalling, glucose regulation, energy balance and body weight.
Does Retatrutide 25 mg represent an approved dose? +
No. The 25 mg designation describes the nominal amount stated for the container. Retatrutide does not currently have an approved public dosing schedule or an authorized 25 mg pharmaceutical presentation, and the vial quantity must not be interpreted as a recommended individual dose.
What potential effects of retatrutide are being studied? +
Clinical trials are evaluating retatrutide for obesity, overweight, type 2 diabetes and related metabolic conditions. Research has examined body-weight reduction, appetite, glucose-related measurements, body composition, cardiometabolic markers and liver fat, but these potential effects remain investigational.
Is Retatrutide approved for public or medical use? +
No. Retatrutide has not been approved by the FDA or another regulatory authority for public use. Its safety and efficacy are still being evaluated through clinical trials, and products offered outside authorized research should not be represented as approved medicines.
What safety information is known about retatrutide? +
The most frequently reported adverse events in clinical research have involved the gastrointestinal system, including nausea, diarrhoea, vomiting and constipation. Increased heart rate has also been observed, and the long-term safety profile remains under evaluation. Retatrutide should not be self-administered or used outside an authorized clinical trial.






